Cargando…
Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis()
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187865/ https://www.ncbi.nlm.nih.gov/pubmed/35697538 http://dx.doi.org/10.1016/j.therap.2022.05.006 |
| _version_ | 1784725249109000192 |
|---|---|
| author | Murarasu, Anne Bertoliatti-Fontana, Gabriel Massy, Nathalie Bagheri, Haleh Treluyer, Jean-Marc Regent, Alexis Chouchana, Laurent |
| author_facet | Murarasu, Anne Bertoliatti-Fontana, Gabriel Massy, Nathalie Bagheri, Haleh Treluyer, Jean-Marc Regent, Alexis Chouchana, Laurent |
| author_sort | Murarasu, Anne |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9187865 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91878652022-06-13 Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis() Murarasu, Anne Bertoliatti-Fontana, Gabriel Massy, Nathalie Bagheri, Haleh Treluyer, Jean-Marc Regent, Alexis Chouchana, Laurent Therapie Letter to the Editor Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2023 2022-05-21 /pmc/articles/PMC9187865/ /pubmed/35697538 http://dx.doi.org/10.1016/j.therap.2022.05.006 Text en © 2022 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Murarasu, Anne Bertoliatti-Fontana, Gabriel Massy, Nathalie Bagheri, Haleh Treluyer, Jean-Marc Regent, Alexis Chouchana, Laurent Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis() |
| title | Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis() |
| title_full | Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis() |
| title_fullStr | Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis() |
| title_full_unstemmed | Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis() |
| title_short | Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis() |
| title_sort | immune thrombocytopenia following chadox1 vaccine and positive rechallenge with bnt162b2 vaccine: a case report with pharmacovigilance analysis() |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187865/ https://www.ncbi.nlm.nih.gov/pubmed/35697538 http://dx.doi.org/10.1016/j.therap.2022.05.006 |
| work_keys_str_mv | AT murarasuanne immunethrombocytopeniafollowingchadox1vaccineandpositiverechallengewithbnt162b2vaccineacasereportwithpharmacovigilanceanalysis AT bertoliattifontanagabriel immunethrombocytopeniafollowingchadox1vaccineandpositiverechallengewithbnt162b2vaccineacasereportwithpharmacovigilanceanalysis AT massynathalie immunethrombocytopeniafollowingchadox1vaccineandpositiverechallengewithbnt162b2vaccineacasereportwithpharmacovigilanceanalysis AT bagherihaleh immunethrombocytopeniafollowingchadox1vaccineandpositiverechallengewithbnt162b2vaccineacasereportwithpharmacovigilanceanalysis AT treluyerjeanmarc immunethrombocytopeniafollowingchadox1vaccineandpositiverechallengewithbnt162b2vaccineacasereportwithpharmacovigilanceanalysis AT regentalexis immunethrombocytopeniafollowingchadox1vaccineandpositiverechallengewithbnt162b2vaccineacasereportwithpharmacovigilanceanalysis AT chouchanalaurent immunethrombocytopeniafollowingchadox1vaccineandpositiverechallengewithbnt162b2vaccineacasereportwithpharmacovigilanceanalysis |